WATCH THE REPLAY

Webinar: Optimizing your pre-launch activities to impact time to peak sales

The commercialization process for a new drug is long, complex and expensive. For biopharma companies, bringing a drug to market typically takes 10-15 years and can require more than $2 billion dollars. With this level of investment, it’s generally important to look across each phase of commercialization and identify areas of optimization to maximize the timeline to peak sales. That said, the most successful organizations ensure they’ve built a strong foundation in the early phases of commercialization so they can start the journey on the ‘right foot’.

In this 30-minute session, Robert Groebel, VP of Global Life Sciences Strategy at Definitive Healthcare will lead a discussion on how to optimize the key pre-launch activities which can positively impact your timeline to peak sales. Join live to learn:

  • How to select the fastest recruiting trial sites and investigators
  • Strategies to remove data silos across clinical and commercial teams
  • Ways to engage KOLs to identify scientific and competitive intelligence

 

About the speaker

Robert Groebel, VP, Global Medical Strategy

Robert Groebel is the Global VP of Medical Strategy at Definitive Healthcare. He is recognized for his ability to create a strategic vision and accelerate innovation via technology. Most recently, he was the Global Vice President, Medical & Account Management Strategy at Veeva Systems. He has more than 25 years of healthcare experience holding global medical and commercial roles at both Boehringer Ingelheim and Shire Pharmaceuticals. In his current role, he guides commercial & medical affairs organizations globally to leverage technology, data, and analytics to enhance engagement, scientific, communications, and account management strategies in today’s increasingly complex healthcare landscape.

 

 

Explore our data